CMBA
AVNS icon

C.M. Bidwell & Associates’s Avanos Medical AVNS Stock Holding History

C.M. Bidwell & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,810
Closed -$479K – 233
2016
Q3 		$479K Buy
+13,810
New +$484K 0.11% 100

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

C.M. Bidwell & Associates's AVNS Position: Q4 2016 in Review

C.M. Bidwell & Associates sold out of Avanos Medical (AVNS) in Q4 2016, closing a stake of 13,810 shares — an estimated $479K sold.

C.M. Bidwell & Associates first reported a position in AVNS in Q3 2016 and held it in 1 quarter. The position peaked at $479K in Q3 2016. 359 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

  • C.M. Bidwell & Associates reported no remaining Avanos Medical position as of Q4 2016 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 13,810 Avanos Medical shares in Q4 2016, an estimated $479K.
  • C.M. Bidwell & Associates first reported a position in Avanos Medical in Q3 2016 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Avanos Medical position peaked at $479K in Q3 2016.
  • 359 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2016, filed 13 Feb 2017.